ADRs Flashcards

1
Q

to be rational, drug therapy must include consideration of (3)

A

drug, host and disease factors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

a goal of successful drug therapy is to achieve effective _____________ of ___________________ at __________________ in __________________

A

concentrations; the appropriate drug; the site of drug action; the individual

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

most drug therapies are based on

A

fixed dosage regimens

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what are some host factors that would necessitate adjusting the dosage regimen

A

neonatal patient, geriatric patient, pregnant/lactating patient, species/breeds

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what are some disease factors that would necessitate adjusting the dosage regimen

A

renal disease, hepatic disease, cardiovascular disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

what are some drug factors that would necessitate adjusting the dosage regimen (think broad)

A

pharmaceutical interactions, pharmacokinetic interactions, pharmacodynamic interactions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what is an ADR

A

unintended and usually noxious response to a drug that is unwanted

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

T/F ADRs occur at drug doses used for prophylaxis, treatment, or diagnosis

A

T

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

An estimated _____________ percentage of all hospitalized human patients are admitted due to an ADR

A

3-5%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

what are the 6 most common drug classes to produce ADRs

A

1) NSAIDS
2) vaccines
3) antimicrobials
4) ectoparasitides
5) antihelmintics
6) anesthetic agents

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what are the two types of ADRs? which is avoidable?

A

Type A and Type B; Type A is avoidable

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

what is the most common type of ADR

A

Type A

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what are 3 characteristics of Type A ADRs

A

dose-dependent and predictable; experimentally reproducible; mechanism responsible is known

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

why do Type A ADRs alter plasma drug levels

A

change in the drug disposition (absorption, distribution, metabolism, excretion)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

what are the 2 subtypes of Type A ADRs

A

pharmacological, intrinsic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

describe pharmacological Type A ADRs

A

exaggerated pharmacological effects of the drug due to too much of the drug on its intended target receptor, or an off-target receptor (the right receptor in the wrong location)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

an example of pharmacological type A ADRs is

A

propanolol (induced bradycardia in patients with higher than expected blood levels)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

xylazine-induced emesis, propanolol-induced bronchospasm, and NSAID induced GI ulcers are examples of

A

Type A pharmacological ADRs due to off-target effects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

describe intrinsic Type A ADRs

A

determined by the drugs physio-chemical properties, binding of metabolites to non-specific targets that disrupts organelles and membranes, nucleic acids and proteins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

T/F pharmacological Type A ADRs are often dependent on bioactivation

A

F; intrinsic Type A ADRs are

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

the site of Type A intrinsic ADRs is dependent on (3)

A

cells/tissues that accumulate drug, location of metabolizing NZs, susceptibility of tissues

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

describe Type B ADRs

A

dose independent and unpredictable; not experimentally reproducible; host dependent

23
Q

what are the two subtypes of Type B ADRs

A

immunological and idiosyncratic

24
Q

what is the main form of Type B ADRs

A

immunological

25
describe immunological Type B ADRs
the drug (or metabolite) acts as a hapten on endogenous molecules, inciting type I-IV reactions
26
penicillin-induced allergies in dogs are what type of ADR
immunological Type B ADRs
27
how are intrinsic and idosyncratic ADRs similar
they usually involve bioactivation of the drug
28
describe idiosyncratic Type B ADRs
mechanism of action is usually unrelated to the pharmacologic action, or is unknown; involves bioactivation and depends on the chemical property of the drug
29
oral diazepam in cats and carprofen in dogs are examples of
Type B idiosyncratic ADRs
30
clinical signs of an ADR are usually _____________ and rarely ___________________
non-specific; pathognomonic
31
we diagnose ADRs based on
strength of association
32
systemic effects are often seen with Type A or Type B ADRs
Type B
33
T/F use of corticosteroids for all ADRs is well documented
F; only good for immunologic ADRs
34
the most important step when treating an ADR is __________________; the rest of treatment is based on ________________ and _________________
drug withdrawal; clinical manifestation of the drug; supportive care
35
In Canada, ADRs are reported on a (voluntary/involuntary) basis
voluntary
36
most clinically significant ADRs are due to ___________________ in the target species
altered drug disposition
37
what are some species differences that can lead to an ADR (4)
1) GI tract 2) body composition 3) blood volume 4) drug metabolism
38
what are some differences between geriatric and neonatal patients that can predispose to an ADR
geriatric: diminished organ function, altered body composition neonatal: increased bioavailability, larger Vd, slower elimination
39
the most profound changes in drug disposition are found with a decline in what organ function
renal function
40
give 3 reasons why the kidneys are highly vulnerable to ADRs
1) kidneys receive 20-25% of cardiac output 2) kidneys concentrate drugs and toxins 3) kidneys have high metabolic activity
41
T/F uremia can reduce protein binding and hepatic metabolism of some drugs
T
42
you have a patient with CRF; what are 3 considerations when prescribing this patient medications
1) avoid drugs eliminated by the kidneys 2) avoid drugs that are toxic to the kidneys 3) dose adjustment
43
what 2 classes of drugs are capable of renal ADRs
NSAIDs, aminoglycosides
44
you have a patient with cardiac disease; what are 3 considerations before giving this patient medications
1) give critical drugs IV 2) give toxic drugs IV slowly 3) dose adjustments
45
what are 3 consequences of liver disease that can predispose to ADRs
1) reduced renal blood flow 2) reduced enzyme function 3) increased fraction of plasma unbound drug
46
you have a patient with liver disease; what are 3 considerations before prescribing this patient medication
1) dose adjustments 2) choose drugs that are mainly eliminated not by the liver (i.e. not in bile) 3) avoid the liver when possible
47
what is a drug interaction
change in the magnitude or duration of a pharmacologic effect of a drug due to the presence of another drug, food or environment factor
48
T/F drug interactions can occur before or after the drug is absorbed by the host
T
49
drug interactions are classified as (3)
pharmaceutical, pharmacokinetic, pharmacodynamic
50
pharmaceutical interactions occur __________________ and can be classified as (3)
before the drug is absorbed by the host; drug-drug; drug-diet; drug-environment
51
what is the most common type of drug interaction
pharmacokinetic
52
pharmacokinetic interactions depend on
changes in drug disposition
53
pharmacodynamic interactions occur when
one drug directly alters the physiologic or cellular response to another drug
54
pharmacodynamic interactions can be further classified as (3)
receptor interactions; post-receptor interactions; physiologic response interaction